Manufacturing & Bioprocessing - software & AI news

Daily news on software, AI, and companies shaping manufacturing & bioprocessing.

Showing 42 results
A minimalist representation of a gear and circuit board in a dark palette, symbolizing medical technology collaboration.

Jul 7, 2026

PDV MedTech Inc.; Corscience

PDV MedTech and Corscience have formed a strategic partnership aimed at enhancing the development and manufacturing of medical technologies across the U.S. and Europe.This collaboration merges Corscience's engineering expertise in complex medical devices with PDV MedTech's robust U.S. manufacturing capabilities. The goal is to streamline the journey from concept to commercialization for safety-critical medical devices, addressing common challenges such as regulatory compliance, design for manufa
A test tube in a dimly lit lab

Jul 6, 2026

Katalyze AI raises $10.5M to deploy agent teams

Katalyze AI has successfully secured $10.5 million in seed funding aimed at enhancing its agent teams focused on pharmaceutical manufacturing and life sciences operations.This funding round, reported by BetaKit and TechStartups, signals a significant shift in the application of agentic AI, moving from experimental demonstrations to practical applications within regulated environments. Key integrations with systems such as Manufacturing Execution Systems (MES), Laboratory Information Management S
A minimalist illustration of a pill bottle and an AI agent silhouette on a solid background.

Jul 6, 2026

Katalyze AI thinks the future of pharma operations is teams of AI agents

Katalyze AI has secured $10.5 million in seed funding to enhance drug development through AI-driven operational efficiencies.The startup, Katalyze AI, is developing a platform designed to enable pharmaceutical companies to assemble teams of AI agents for various tasks, including engineering and manufacturing. This innovative approach aims to streamline operations within the pharma sector, which traditionally faces lengthy and costly drug development processes. With the recent funding led by Bonf
A minimalist representation of financial growth with a dollar sign and a circular shape.

Jul 6, 2026

Katalyze AI Raises $10.5M in Seed Funding

Katalyze AI has successfully secured $10.5 million in Seed funding to enhance its innovative operating system tailored for pharmaceutical companies.The funding round, spearheaded by Bonfire Ventures, saw participation from Inovia Capital, Ripple Ventures, Alumni Ventures, and notable angel investors such as Gokul Rajaram and Farzad Soleimani. This financial boost is aimed at expanding Katalyze AI's operations and furthering its development initiatives.Under the leadership of CEO Reza Farahani, K
A clear vial of liquid on a lab bench with blurred lab equipment in the background.

Jul 6, 2026

Katalyze AI Raises $10.5M to Build the Agentic Operating System for Pharmaceutical Companies

Katalyze AI has secured $10.5 million in seed funding to enhance its agentic operating system tailored for pharmaceutical companies, aiming to streamline complex processes in drug development.This funding round, led by Bonfire Ventures with participation from several other investors, underscores the urgent need for innovation in the pharmaceutical sector, where challenges such as patent expirations and drug shortages are mounting. Katalyze AI's platform allows scientists and engineers to create
A minimalist illustration of a vaccine vial and a cell on a dark background.

Jun 29, 2026

China’s first AI-powered cancer vaccine production line set to launch in Beijing

China is launching its first production line for AI-assisted personalized cancer vaccines, a significant advancement in the fight against cancer, which is the second leading cause of death in the country.Beijing-based Likang Life Sciences is set to complete a new drug research and manufacturing center in the Beijing Economic and Technological Development Zone by October. This facility, with an investment of approximately 110 million yuan (around US$16.1 million), will focus on developing cell th
A minimalist representation of a banknote symbolizing funding in biotechnology.

Jun 27, 2026

Immuneel Therapeutics Secures Over INR 100 Cr Series B Funding

Bengaluru-based Immuneel Therapeutics has successfully raised over INR 100 crore in its Series B funding round, with backing from both existing and new investors. This funding is set to enhance their manufacturing capabilities, advance their therapy pipeline, and facilitate entry into international markets.The funding round attracted notable participation from new investors, including Singularity AMC and Rainmatter by Zerodha, alongside continued support from existing investors like Kiran Mazumd
A minimalist representation of a drug compound in flat design.

Jun 26, 2026

AI in Biologics CDMO Workflows: A BIO Conversation with Lonza

At the 2026 BIO International Convention, Zara Asgharpour, Head of External Innovation Integrated Biologics at Lonza, highlighted the transformative potential of artificial intelligence (AI) in biologics workflows. Her insights emphasized the integration of AI across the entire biopharmaceutical value chain, from drug discovery to manufacturing and clinical trials.Asgharpour articulated that AI is set to revolutionize the operations of Contract Development and Manufacturing Organizations (CDMOs)
A minimalist representation of a pill and an API silhouette in a dark color scheme.

Jun 24, 2026

India needs quantum jump into manufacturing high-value pharma products: Economists

India's pharmaceutical sector is being urged to enhance its focus on high-value products, including Active Pharmaceutical Ingredients (APIs), according to economists who referenced a recent NITI Aayog report. The report highlights India's strengths in generic medicines and vaccines but calls for a strategic shift to boost exports of higher-value pharmaceuticals.Economist Ved Jain emphasized the need for substantial investment in research and innovation to develop basic drugs and manufacturing fa
A minimalist illustration of a syringe and vial in flat design.

Jun 23, 2026

Pharma MES 2026

The Pharma MES 2026 event is set to connect over 750 industry professionals, focusing on the evolving landscape of manufacturing in the life sciences sector.The life sciences industry faces mounting pressure to enhance product quality while reducing costs and improving operational efficiency. To meet these demands, organizations are increasingly adopting intelligent and sustainable manufacturing solutions that ensure compliance with current good manufacturing practices (cGMP) while facilitating
A minimalist illustration of a vaccine vial and production line in flat design.

Jun 23, 2026

AI in Pharma Manufacturing Market Size, Share | Growth [2034]

The global market for AI in pharmaceutical manufacturing is on a significant growth trajectory, with projections indicating an increase from USD 1.64 billion in 2026 to USD 12.90 billion by 2034, achieving a compound annual growth rate (CAGR) of 29.45%.This expansion is driven by the increasing complexity of drug production, particularly in biologics, vaccines, and advanced therapies, which necessitate faster production cycles and enhanced quality control. AI technologies are being integrated in
Fermentation tank in a biomanufacturing facility

Jun 22, 2026

ChemT Biotechnology Raises US$5 Million to Advance AI-Powered Biomanufacturing Platform

ChemT Biotechnology has successfully raised $5 million in funding to enhance its AI-driven biomanufacturing platform, with the seed round led by Wavemaker Ventures and participation from various notable investors.The funding consists of $1 million from angel investors and $4 million from a seed round aimed at expanding ChemT's AI capabilities and experimental infrastructure. The company's innovative approach seeks to streamline the manufacturing of biologics, which often face challenges such as